Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,795 | 39,553 | 41,193 | 32,672 | 30,912 |
| Marketable Securities | 411,858 | 224,976 | 254,929 | 301,753 | 337,450 |
| TOTAL | $575,760 | $284,810 | $305,403 | $345,184 | $378,323 |
| Non-Current Assets | |||||
| PPE Net | 9,764 | 3,223 | 3,266 | 3,500 | 3,564 |
| Investments And Advances | 4,671 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 51,342 | 5,221 | 5,340 | 3,492 | 2,993 |
| TOTAL | $65,777 | $8,444 | $8,606 | $6,992 | $6,557 |
| Total Assets | $641,537 | $293,254 | $314,009 | $352,176 | $384,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,935 | 20,825 | 16,296 | 15,351 | 13,495 |
| Accrued Expenses | 12,877 | 8,596 | 6,825 | 9,081 | 7,719 |
| TOTAL | $40,463 | $32,610 | $26,321 | $27,723 | $24,556 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,662 | 2,080 | 2,121 | 2,240 | 2,320 |
| Other Non-Current Liabilities | 48,182 | 1,456 | 1,743 | 2,024 | 2,300 |
| TOTAL | $53,326 | $6,528 | $7,358 | $8,125 | $8,952 |
| Total Liabilities | $93,789 | $39,138 | $33,679 | $35,848 | $33,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,799 | 54,687 | 54,026 | 53,909 | 53,810 |
| Common Shares | 1,142,218 | 791,968 | 768,012 | 759,432 | 750,564 |
| Retained earnings | -593,605 | -536,147 | -485,168 | -439,173 | -394,182 |
| Other shareholders' equity | -865 | -1,705 | -2,514 | -3,931 | -5,010 |
| TOTAL | $547,748 | $254,116 | $280,330 | $316,328 | $351,372 |
| Total Liabilities And Equity | $641,537 | $293,254 | $314,009 | $352,176 | $384,880 |